Jenny Ottosson

AstraZeneca (Sweden) — Sweden

Medicine · Health Sciences

18h-index3.6kcitations54works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(14), Enzyme Catalysis and Immobilization(10), Protein purification and stability(10), Analytical Chemistry and Chromatography(8), Advanced Proteomics Techniques and Applications(7)

Publications54 total

Early clinical drug product shelf-life setting using accelerated predictive stability and metabolite data for impurity qualification: A case study
Journal of Pharmaceutical Sciences·2024
Development of hydrolytic stability screening methods for early drug discovery with high differentiation and predictive power
Journal of Pharmaceutical and Biomedical Analysis·2023· 2 cited
CCDC 2112038: Experimental Crystal Structure Determination
The Cambridge Structural Database·2021Open Access
CCDC 2112035: Experimental Crystal Structure Determination
The Cambridge Structural Database·2021Open Access
CCDC 2112034: Experimental Crystal Structure Determination
The Cambridge Structural Database·2021Open Access
CCDC 2112039: Experimental Crystal Structure Determination
The Cambridge Structural Database·2021Open Access
CCDC 2112036: Experimental Crystal Structure Determination
The Cambridge Structural Database·2021Open Access
Understanding Crystal Structures to Guide Form Selection of Active Pharmaceutical Ingredients: A Case Study of AZD9567
Crystal Growth & Design·2021· 8 cited
The Degradation Map Process – A Tool for Obtaining a Lean Stability Strategy in Drug Development
Journal of Pharmaceutical Sciences·2021· 3 cited
Characterization and demonstration of drug compound ring-chain tautomer formation and its impacts on quality control
Journal of Pharmaceutical and Biomedical Analysis·2021· 27 cited
Qualification of impurities based on metabolite data
Regulatory Toxicology and Pharmacology·2019· 18 cited
Experimental and Quantum Chemical Evaluations of Pyridine Oxidation Under Drug Development Stress Test Conditions
Journal of Pharmaceutical Sciences·2015· 2 cited
Att få leva tills man dör : En litteraturstudie om vad som främjar livskvalitén hos patienter med cancer i den palliativa vårdens första fas.
KTH Publication Database DiVA (KTH Royal Institute of Technology)·2015Open Access
Parallel production and verification of protein products using a novel high‐throughput screening method
Biotechnology Journal·2011· 10 cited
Surrogate antigens as targets for proteome-wide binder selection
New Biotechnology·2011· 11 cited
Enhancing the protein production levels in <i>Escherichia coli</i> with a strong promoter
FEBS Journal·2010· 102 cited
Antigenic mapping and characterization of Albumin Binding Protein
Journal of Medical Entomology·2010
The correlation between antigen solubility and immunogenicity
2010
Increased levels of recombinant human proteins with the Escherichia coli strain Rosetta(DE3)
Protein Expression and Purification·2009· 133 cited
Using EnBase™ to enhance recombinant protein production
New Biotechnology·2009
page 1 of 3Next →

Frequent Co-authors

Sophia Hober(20), Mathias Uhlén(15), Hanna Tegel(14), Johanna Stéen(10), Karl Hult(9), Henrik Wernérus(7), Peter Nilsson(6), Anja Persson(6), Maria Stenvall(6), Erik Björling(5), Caroline Kampf(5), Kenneth Wester(5), Fredrik Pontén(5), Sten O. Nilsson Lill(5), Cristina Al‐Khalili Szigyarto(4), Anna Asplund(4), Lisa Berglund(4), Karin Larsson(4), Samuel Tourle(4), Antti Vasala(4)